ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
ResMed's Relative Strength Rating rose to 82, surpassing 80% of all stocks. The company's EPS and revenue growth have been strong, leading to a 34% surge in earnings last quarter.